Related Experiment Video
Updated: Aug 2, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Case report: reporting anti-G as anti-C+D may have misleading clinical implications
A L Mosley1, M B Trich, N C Thomas
1Department of Pathology, Georgetown University Medical Center, Washington, DC, USA.
Insights
A D- male developed anti-G antibodies after transfusion, not anti-C+D as initially suspected. This highlights the importance of accurate blood group serology to avoid misinterpreting alloimmunization.
Area of Science:
- Transfusion Medicine
- Blood Group Serology
- Immunology
Background:
- Alloimmunization to red blood cell (RBC) antigens can complicate transfusions.
- Accurate identification of antibodies is crucial for patient safety.
- The D antigen and related antigens (C, G) are significant in transfusion medicine.
Purpose of the Study:
- To investigate a case of suspected anti-D alloimmunization in a D- individual.
- To differentiate between anti-C+D and anti-G antibodies.
- To emphasize the importance of accurate blood group serology interpretation.
Main Methods:
- Standard pretransfusion antibody screening and alloantibody identification panel.
- Review of hospital transfusion records.
- Consultation with a reference laboratory.
- Additional serologic testing for antibody identification.
Main Results:
- An antibody initially reported as anti-C+D was detected in a D- male after transfusion with D- RBCs.
- Further testing confirmed the antibody was anti-G, not anti-C+D.
- The stimulus for anti-G was identified as a C+D- RBC unit from a G+ donor.
Conclusions:
- Serologic reactions for anti-C+D can be mistaken for anti-G.
- Misinterpretation can lead to erroneous conclusions about alloimmunization and transfusion history.
- Confirmatory testing and awareness of anti-G are essential for healthcare providers.
Abstract:
Four months after a D- male was transfused with four units of D- red blood cells (RBCs), the results of a standard pretransfusion antibody screen and alloantibody identification panel detected anti-C+D in his serum. This report was interpreted by his physician to be evidence of alloimmunization to the D antigen, which triggered concern that the patient had been transfused previously with D+ RBCs as the result of an error in blood typing or personal identification. After a review of hospital records failed to identify such an error, consultation with a reference laboratory technologist confirmed that the serologic reactions resembled those of anti-C+D but were also consistent with anti- C + anti-G. Additional testing confirmed that the reactions were due to anti-G, not anti-C+D. One of the four donors was identified to have the C+D- RBC phenotype, which is typically G+, thus identifying the stimulus for anti-G. Routine reporting of the detection of anti-C+D in the serum of D- people, without confirmatory testing or commentary about the possibility that anti-G may resemble anti-C+D, may mislead health care providers who are not familiar with the pertinent blood group serology.
Related Concept Videos
Cross-reactivity
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

